Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
setrobuvir (RG7790) (formerly ANA598)
print preview
bookmark
share with colleague
General Information
Company
Roche
Description
Oral non-nucleoside non-structural protein 5B (NS5B) polymerase inhibitor
Molecular Target
HCV NS5B polymerase
Mechanism of Action
Non-nucleoside polymerase inhibitor
Latest Stage of Development
Phase II
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy